Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Cash from Investing Activities (2016 - 2018)

Historic Cash from Investing Activities for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$535000.0.

  • Armata Pharmaceuticals' Cash from Investing Activities fell 287222.22% to -$535000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was -$597000.0, marking a year-over-year decrease of 92931.03%. This contributed to the annual value of -$1.9 million for FY2024, which is 7689.94% up from last year.
  • Armata Pharmaceuticals' Cash from Investing Activities amounted to -$535000.0 in Q4 2018, which was down 287222.22% from -$11000.0 recorded in Q3 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Cash from Investing Activities peaked at -$2000.0 during Q2 2017, and registered a low of -$831000.0 during Q2 2014.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$34000.0 (2015), whereas its average is -$127500.0.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first soared by 9891.7% in 2015, then plummeted by 287222.22% in 2018.
  • Quarter analysis of 5 years shows Armata Pharmaceuticals' Cash from Investing Activities stood at -$5000.0 in 2014, then tumbled by 900.0% to -$50000.0 in 2015, then soared by 74.0% to -$13000.0 in 2016, then crashed by 38.46% to -$18000.0 in 2017, then tumbled by 2872.22% to -$535000.0 in 2018.
  • Its Cash from Investing Activities stands at -$535000.0 for Q4 2018, versus -$11000.0 for Q3 2018 and -$18000.0 for Q4 2017.